Public Comments to Agencies
Comment to CMS - Medicaid Fiscal Accountability Regulation (MFAR)
Medicaid is a federal and state funded program but is administered by the states.
CAGW Submits Comments to CMS on Transparency Rule
CAGW has long advocated for more market forces to be used in the U.S. healthcare system.
Coalition Comments on Biosimilar and Interchangeable Insulin Guidance
CAGW and coalition partners share the FDA's deep commitment to the development of a robust biosimilars market and appreciate the Agency’s work to develop an efficient approval pathway for biosimilars to bring savings and access to America’s patients.
Coalition Urges Significant Changes to Proposed Commerce Rule
Coalition of taxpayer and consumer advocacy groups urges signficant changes to proposed Commerce rule that would grant broad, undefined powers to the deparment over small businesses.
CAGW Writes to the Food and Drug Administration on Required Warnings for Cigarette Packages and Advertisements
CAGW writes concerns to the Food and Drug Administration about label warnings for cigarette packages and advertisements.
CAGW Submits Comments to Bureau of Consumer Financial Protection on Payday Lending Rule
May 14, 2019 The Honorable Kathy Kraninger Director Bureau of Consumer Financial Protection 1700 G Street, NW Washington, D.C., 20552 Dear Director Kraninger:
CAGW Submits Comments to FDA on Biological Product INNs
April 30, 2019 Food and Drug Administration Dockets Management Staff (HFA-305) 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Docket No. FDA-2013-D-1543 Nonproprietary Naming of Biological Products: Update; Draft Guidance for Industry;...
Coalition Comments to FCC on KidVid Regulations
March 26, 2019 VIA ELECTRONIC SUBMISSION Marlene H. Dortch Secretary Federal Communications Commission 44512th Street, SW Washington, DC 20554
CAGW Joins Coalition to Support FHFA Rule on Alternative Credit Score Models
March 21, 2019 Alfred M. Pollard, General Counsel Federal Housing Finance Agency 400 Seventh St. NW, 8th Floor Washington, DC 20219 Attention: Comments/ RIN 2590-AA98: Validation and Approval of Credit Score Models by Fannie Mae and Freddie Mac
CAGW: FDA Should Embrace Harm Reduction, Approve Modified Risk Tobacco Product Application
January 8, 2019 Food and Drug Administration Dockets Management Staff (HFA-305) 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: U.S. Smokeless Tobacco Company, LLC. MRTP Application for Copenhagen Snuff Docket FDA-2018-N-3261
CAGW Submits Comments to the Federal Trade Commission on Competition and Consumer Protection in the 21st Century relating to innovation and intellectual property rights
December 21, 2018 Federal Trade Commission 600 Pennsylvania Avenue, N.W. Washington, D.C. 20580 Ref: Docket ID: FTC-2018-0090 Dear Commissioners,
CAGW Joins Coalition Advocating for Television White Space Technology
December 4, 2018
